SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. (Q52677129)
Jump to navigation
Jump to search
scientific article published on 2 March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. |
scientific article published on 2 March 2018 |
Statements
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma (English)
Mihir Gandhi
Say-Beng Tan
Maung Win Khin
Ariunaa Khasbazar
Janus Ong
Su Pin Choo
Peng Chung Cheow
Chanisa Chotipanich
Kieron Lim
Laurentius A Lesmana
Tjakra W Manuaba
Boon Koon Yoong
Aloysius Raj
Chiong Soon Law
Ian H Y Cua
Rolley R Lobo
Catherine S C Teh
Yun Hwan Kim
Yun Won Jong
Ho-Seong Han
Si-Hyun Bae
Hyun-Ki Yoon
Rheun-Chuan Lee
Chien-Fu Hung
Cheng-Yuan Peng
Adam Bartlett
Choon-Hua Thng
Albert Su-Chong Low
Anthony S W Goh
Kiang Hiong Tay
Richard H G Lo
Brian K P Goh
David C E Ng
Ganesh Lekurwale
Wei Ming Liew
Val Gebski
Kenneth S W Mak
Khee Chee Soo
Asia-Pacific Hepatocellular Carcinoma Trials Group